Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's disease

Nat Commun. 2024 Jan 3;15(1):202. doi: 10.1038/s41467-023-44374-w.

Abstract

In Alzheimer's disease, amyloid-beta (Aβ) triggers the trans-synaptic spread of tau pathology, and aberrant synaptic activity has been shown to promote tau spreading. Aβ induces aberrant synaptic activity, manifesting in increases in the presynaptic growth-associated protein 43 (GAP-43), which is closely involved in synaptic activity and plasticity. We therefore tested whether Aβ-related GAP-43 increases, as a marker of synaptic changes, drive tau spreading in 93 patients across the aging and Alzheimer's spectrum with available CSF GAP-43, amyloid-PET and longitudinal tau-PET assessments. We found that (1) higher GAP-43 was associated with faster Aβ-related tau accumulation, specifically in brain regions connected closest to subject-specific tau epicenters and (2) that higher GAP-43 strengthened the association between Aβ and connectivity-associated tau spread. This suggests that GAP-43-related synaptic changes are linked to faster Aβ-related tau spread across connected regions and that synapses could be key targets for preventing tau spreading in Alzheimer's disease.

MeSH terms

  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Biomarkers / metabolism
  • Brain / metabolism
  • Cognitive Dysfunction* / metabolism
  • GAP-43 Protein / genetics
  • GAP-43 Protein / metabolism
  • Humans
  • Positron-Emission Tomography
  • tau Proteins / metabolism

Substances

  • GAP-43 Protein
  • tau Proteins
  • Amyloid beta-Peptides
  • Biomarkers